Featured Jobs

Retirement Plan Administrator (Kennett Square PA)

Senior Qualified Plan Administrator (Miamisburg OH)

NQ Client Services Manager (Lake Mary FL / Dallas TX)

Regional Sales Vice President, Outside Retirement Sales Consultant (Marlton NJ / Telecommute)

Compliance Manager (Ponte Vedra Beach FL)

Compliance Administrator III (Chico CA / Telecommute)

Free Daily News and Jobs

“BenefitsLink continues to be the most valuable resource we have at the firm.”

-- An attorney subscriber

Get the BenefitsLink app LinkedIn

News Items, by Subject (Headlines)

Health plan costs - prescription drugs

Now Viewing Headlines View Excerpts and

Wasteful Drug Spending Contributes to High Prescription Costs
2020 Global Medical Trend Rates Report
[Guidance Overview] Two Interesting New Rules Regarding Prescription Drugs -- What Is Really Going On?
Eliminating Pharmacy Waste -- It's Not Easy
Pharma CEOs Shower GOP Senators with Campaign Cash
Reducing Wasteful Spending in Employers' Pharmacy Benefit Plans
Plans Need Not Count Drug Manufacturer Coupons Toward the ACA's Cost-Sharing Annual Limits
[Guidance Overview] 2020 Drug Coupon Rule Dropped Due to Implementation Concerns
HHS Walks Back New Policy on Drug Coupons
The New Hospital Price Disclosure Rule Is Important, But Only a First Step
Administration Again Attempts to Lower Drug Prices
Maximizing a Pharmacy Benefit Program: Innovative Solutions for Employers
Shopping Abroad for Cheaper Medication? Here's What You Need To Know
Amazon Mail-Order Pharmacy Faces Pushback
Follow the Scripts: Trends in ERISA Litigation Against PBMs
Drug Pricing and Surprise Billing: Recent Actions and Outlook
Congress and Administration Consider Significant Drug Pricing Policy Changes
Administration Announces Plan to Permit Drug Importation
Trump Administration 'Open for Business' on Drug Imports from Canada
[Official Guidance] HHS Announces New Action Plan to Lay Foundation for Safe Importation of Certain Prescription Drugs
Medicare Part D Prescription Drug Plan Costs to Decline Again in 2020
Policy Options for Addressing High Drug Prices
[Opinion] Drug Rebates Will Remain, But So Will Pressure to Reduce Drug Prices and Demonstrate Value
A Small Group of Patients Facing High Drug Costs Drive Health Care Spending
Prescription Drug Rebates, Explained
Understanding the Senate Finance Committee's Drug Pricing Package
Is Prescription Drug Pricing the Cure for Partisanship?
Senate Finance Committee Passes Drug Pricing Package
Senate Finance Committee Unveils Bipartisan Bill to Lower Drug Costs
Senate Hearings On Drug Prices: Many Questions, Few (Useful) Answers
Rising Generic Prices Help Drive Up Cost of WHO List of Essential Medicines in US
[Opinion] There Is No Single, Best Policy for Drug Prices
How Blockchain Technology Will Disrupt the PBM-Payer-Pharmacy Relationship
Administration Drops Plan to Curb Drug Rebates
Will Prescription Drug Price Disclosures Have an Impact?
How to Get a Cheaper Prescription Before Leaving the Doctor's Office
Drug Price Disclosures and the First Amendment
District Court Vacates HHS Rule That Would Require Drug Price Disclosure in TV Ads
Supreme Court Seeks Solicitor General's Input on ERISA Preemption of State Regulation of Pharmacy Benefit Managers
[Opinion] Maryland's Path to a Prescription Drug Affordability Board
Rebalancing High Prescription Drug Prices with Innovation Incentives
Pelosi Aims for Feds to Negotiate Drug Prices, Even for Private Insurers
New Texas Law Mandating Drug Price Transparency Considered Among Strongest in Nation
[Opinion] A Simple Solution to Lower Drug Prices for All Americans
[Guidance Overview] Oklahoma Enacts Regulation of Pharmacy Benefit Managers
Senate Committee Hearing: The Complex Web of Prescription Drug Prices -- Examining Agency Efforts to Further Competition and Increase Affordability
Senate Package Targets Healthcare Costs, Surprise Medical Bills
[Opinion] Transparency, Regulation Needed to Rein in Pharmacy Benefit
How External Reference Pricing Could Address Price Disparities Between Drugs in the U.S. and Other Nations
Witnesses Testify in Review of CVS-Aetna Merger
[Opinion] Transparency Is Just One Piece of the Drug Pricing Puzzle
Arbitration Approach Favored in Pending Surprise-Bill Legislation
Policy Options to Help Self-Insured Employers Improve PBM Contracting Efficiency
Oklahoma Governor Signs Law Regulating PBMs
Bipartisan Support for New Attempts to Control Prescription Drug Costs
How Does Prescription Drug Spending and Use Compare Across Large Employer Plans, Medicare Part D, and Medicaid?
Opioid Prescriptions Drop Sharply Among California State Workers
CBO Reply to Sen. Grassley: Negotiation Over Drug Prices in Medicare
House Passes Legislation to Strengthen the ACA
[Guidance Overview] CMS Takes Action to Lower Prescription Drug Prices and Increase Transparency
© 2019 BenefitsLink.com, Inc.